Acucela Inc. Appoints Michelle Carpenter, J.D., RAC, as Senior Vice President, Regulatory Affairs & Development Operations

SEATTLE--(BUSINESS WIRE)--Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, today announced that it has appointed Michelle Carpenter, J.D., RAC, as senior vice president, regulatory affairs & development operations. As a member of Acucela’s executive team, Ms. Carpenter will be responsible for operational execution of global development programs across all indications from Phase 1 through New Drug Application (NDA), as well as related activities for commercial purposes. She will report to Ryo Kubota, M.D., Ph.D., chairman, president, and chief executive officer, Acucela Inc.

Back to news